KHI Monthly Mixer: Communicating Risk to Potential Clinical Research Participants

On May 20, 2024, KHI's Board of Directors will virtually host the next Monthly Mixer on potential opportunities and risks of emerging biologics products, highlighting the importance of informing and communicating to potential clinical trial participants. Discussions include sharing best practices for communication on the science and potential benefits and risks of emerging biologics therapies, including a framework for informed consent.

Register Today!